Effects of pimobendan on cardiac function,left ventricular remodeling and mortality in rat model of congestive heart failure induced by coronary artery ligation

MENG Fanbo,Tsutomu Yoshikawa,Toshihisa Anzai,Yuichiro Meakawa,Yasuo Sugano,Satoshi Ogawa
DOI: https://doi.org/10.3969/j.issn.1001-1439.2004.12.011
2004-01-01
Journal of Clinical Cardiology
Abstract:Objective: To investigate effects of pimobendan on left ventricular(LV) remodeling, mortality and cardiac function in CHF rats.Method: the rats model of congestive heart failure(CHF )was divided into 4 groups,Ⅰgroup: AMI+vehicles; Ⅱgroup: AMI+pimobendan 0.1 mg/kg; Ⅲgroup: AMI+pimobendan 0.1 mg/kg; Ⅳgroup: sham+vehicles. The pimobendan or vehicles was administrated i.p once a day for 2 weeks.Result:No one rat was death during the intervention period. Cardiac function could be improved and ventricular remodeling could not be affected by i.p pimobendan, once a day; pimobendan 1mg/kg can reduce ventricular remodeling. Conclusion:①there was no effect of pimobendan on mortality of CHF rats ( do not increase mortality). ②there was no effect of pimobendan on LV remodeling of CHF rats ( do not induce LV remodeling), but improve the cardiac performance. ③1 mg/kg pimobendan for i.p once a day can reduce the extent of LV remodeling in CHF rats with whole free wall infraction and cardiotonic effect increase with the increasing of pimobendan.
What problem does this paper attempt to address?